Literature DB >> 15077849

Carinal resection after induction bronchial arterial infusion for locally advanced non-small cell lung cancer.

Tetsuya So1, Toshihiro Osaki, Shoji Nakata, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto.   

Abstract

We herein describe 3 cases of a carinal resection after induction bronchial arterial infusion (BAI) for locally advanced non-small cell lung cancer (NSCLC). Case 1 was a 44-year-old man with T1N2M0 adenocarcinoma. After undergoing Nd-YAG laser treatment (5079 J) and BAI [cis-diamminedichloro platinum (CDDP) 100 mg/body], a right sleeve upper lobectomy with a carinal resection and reconstruction (Montage type) was performed. Case 2 was a 67-year-old man with T4N1M0 squamous cell carcinoma. After BAI (CDDP 120 mg/body), an operation (same as case 1) was performed. Case 3 was a 72-year-old man with T4N2M0 squamous cell carcinoma. After BAI (CDDP 120 mg/body), a right sleeve peumonectomy was performed. There was neither BAI-related intraoperative nor postoperative complications. BAI with CDDP was thus found to be a useful and effective therapeutic modality for locally advanced NSCLC invading the carina.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077849     DOI: 10.1007/s11748-004-0131-y

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  9 in total

1.  Anastomotic complications after bronchoplastic procedures for nonsmall cell lung cancer.

Authors:  E Yatsuyanagi; S Hirata; K Yamazaki; T Sasajima; Y Kubo
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

2.  Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.

Authors:  T W Rice; D J Adelstein; A Koka; M Tefft; T J Kirby; M A Van Kirk; M E Taylor; T E Olencki; D Peereboom; G T Budd
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Selective bronchial arteriography and intra-arterial chemotherapy in carcinoma of the lung.

Authors:  P C Kahn; R E Paul; H F Rheinlander
Journal:  J Thorac Cardiovasc Surg       Date:  1965-11       Impact factor: 5.209

4.  Transverse myelitis following selective bronchial arteriography.

Authors:  H H Feigelson; H A Ravin
Journal:  Radiology       Date:  1965-10       Impact factor: 11.105

5.  Bronchial arterial infusion is an effective therapeutic modality for centrally located early-stage lung cancer: results of a pilot study.

Authors:  T Osaki; T Hanagiri; R Nakanishi; I Yoshino; S Taga; K Yasumoto
Journal:  Chest       Date:  1999-05       Impact factor: 9.410

Review 6.  Current morbidity, mortality, and survival after bronchoplastic procedures for malignancy.

Authors:  M Tedder; M P Anstadt; S D Tedder; J E Lowe
Journal:  Ann Thorac Surg       Date:  1992-08       Impact factor: 4.330

7.  Feasibility of induction chemotherapy using bronchial arterial infusion for locally advanced non-small cell lung cancer: a pilot study.

Authors:  Toshihiro Osaki; Tsunehiro Oyama; Mitsuhiro Takenoyama; Satoshi Taga; Tomoko So; Toshihiro Yamashita; Shoji Nakata; Ryoichi Nakanishi; Kosei Yasumoto
Journal:  Surg Today       Date:  2002       Impact factor: 2.549

Review 8.  [Surgery and adjuvant therapy of non-small cell lung cancer].

Authors:  Y Watanabe; T Yamada; T Ichihashi; Y Hashizume; T Iwa
Journal:  Gan To Kagaku Ryoho       Date:  1986-04

Review 9.  Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2).

Authors:  M G Kris; K M Pisters; R J Ginsberg; J R Rigas; V A Miller; S C Grant; R J Gralla; R T Heelan; N Martini
Journal:  Lung Cancer       Date:  1995-04       Impact factor: 5.705

  9 in total
  3 in total

1.  Sclerosis therapy of bronchial artery attenuates acute lung injury induced by burn and smoke inhalation injury in ovine model.

Authors:  Atsumori Hamahata; Perenlei Enkhbaatar; Hiroyuki Sakurai; Motohiro Nozaki; Daniel L Traber
Journal:  Burns       Date:  2010-04-09       Impact factor: 2.744

Review 2.  Regional chemotherapy of the lung: transpulmonary chemoembolization in malignant lung tumors.

Authors:  Thomas J Vogl; Mohammad Shafinaderi; Stefan Zangos; Sebastian Lindemayr; Khashayar Vatankhah
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

3.  Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer.

Authors:  Huiwei Qi; Sen Jiang; Dong Yu; Huijuan Ni; Qiong Hu; Jie Zhang
Journal:  Med Oncol       Date:  2015-10-23       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.